CHD1 and neoplasm: Functional assays revealed that CHD1 knockdown, in combination with cisplatin treatment, significantly enhanced tumor suppression and reduced the cisplatin IC50 by ~50% compared to cisplatin alone in p53R175G cells (Fig. 8G, H).